National funding

Current Projects:

Amount awarded: €504,000.00

Period: 04/2018 – 03/2022

Science Foundation Ireland Centre grant “FutureNeuro”

Allocated amount to PI: €110,000.00

Period: 09/2017 – 08/2021

  •  Health Research Board (HRA-POR-2015-1243) “Blood adenosine levels as a novel diagnostic of seizures in humans”

Amount awarded: €310,000.00

Period: 03/2016 – 02/2019

  • StAR programme RCSI“Hyperexcitability mediating MicroRNAs as novel diagnostics and therapeutics”

Amount awarded: €150,000.00

Period: 04/2016 – 04/2020

Past Projects:

  • SIRG SFI Starting Investigator Research Grant (13/SIRG/2098 ) “Novel treatments and diagnostics for epilepsy via the ATPgated P2X7 receptor”

Amount of award: €519,000.00

  •  SFI Technology Innovation Development Award (TIDA) “Development of a simple, fast blood test to support seizure diagnosis”

Amount awarded: €90,208.00

Period: 01/2017 – 12/2017

  •  Enterprise Ireland (EI) ”Interdisciplinary training network on the purinergic P2X7 receptor to control neuroinflammation and hyperexcitability in brain diseases”

Amount awarded: €11,627.00

Period: 10/2015 – 06/2016

  •  COEN Network of Centres of Excellence in Neurodegeneration “microRNA as novel therapeutic targets and disease biomarkers in Alzheimer’s Disease, Frontotemporal dementia and Amyotrophic lateral sclerosis (NEURO-MIR)”

Amount of award: €248,819.00 (allocatedto PI: €99,000.00)

Period: 11/2013-10/2015

  •  Enterprise Ireland “P2X7 Receptor as a Target for Therapeutics and Diagnostics in Disorders of the brain”

Amount awarded: €6,600.00

Period: 10/2014 – 07/2015

  •  HRB Health Research Award POR/2012/56 “A novel treatment for neonatal seizures; pharmacologic targeting of the P2X7 receptor”

Amount of award: €154,710.00

Period: 10/2012 – 09/2015

  •  HRB Health Research Award POR/2011/41 “The proteasome as a treatment target for preventing seizure-induced neuronal death and epilepsy”

Amount of award: €247,532.00

Period: 10/2011 – 09/2014

  •  HRB Health Research Award POR/2010/123 “Seizure control in drug-resistant epilepsy by targeting the purinergic P2X7 receptor”.

Amount of award: €230,369.00

Period: 10/2010 – 09/2013

  • HRB Postdoctoral fellowship PD/2009/31 Type: Postdoctoral fellowship “Glycogen synthase kinase -3 as a therapeutic target in seizure-induced neuronal death and epileptogenesis”.

Amount of award: €215, 385.00

Period: 09/2009 – 08/2012

  • IRCSET Postdoctoral fellowship “PUMA in seizure-induced cell death and epileptogenesis”

Amount of award: €230,369.00

Period: 12/2007 – 09/2009